Answers are grounded in this paper and cite their sources.
VKORC1 haplotypes can be used to stratify patients into low-, intermediate-, and high-dose warfarin groups and may explain differences in dose requirements among patients of different ancestries. The molecular mechanism of this warfarin dose response appears to be regulated at the transcriptional level.
No takes yet. Share an insight, caveat, or question.
Rieder et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: